Paper · 15316618
[Limb girdle muscular dystrophies].
Finsterer J. Nervenarzt, 2004. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. [Limb girdle muscular dystrophies]. Papers, record 15316618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15316618
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Predisposition to Disease | Major topic |
| Muscle Proteins | Major topic |
| Muscular Dystrophies, Limb-Girdle | Major topic |
| Humans |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,496,277 | Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. | Neurology | 1999 | https://conductscience.org/library/papers/10496277 | PubMed |
| 2 | 12,587,341 | [Dysferlinopathy. Example of a new myopathy]. | Bull Acad Natl Med | 2002 | https://conductscience.org/library/papers/12587341 | PubMed |
| 3 | 7,663,518 | Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli. | Nat Genet | 1995 | https://conductscience.org/library/papers/7663518 | PubMed |
| 4 | 8,533,766 | Evidence for locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy. | Am J Hum Genet | 1995 | https://conductscience.org/library/papers/8533766 | PubMed |
| 5 | 10,464,299 | Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10464299 | PubMed |
| 6 | 8,499,908 | Exclusion of the 15q locus as a candidate gene for severe childhood autosomal recessive Duchenne-like muscular dystrophy in Brazilian families. | Hum Mol Genet | 1993 | https://conductscience.org/library/papers/8499908 | PubMed |
| 7 | 14,960,875 | Screening for C283Y gamma-sarcoglycan mutation in a high-risk group of Bulgarian Gypsies: evidence for a geographical localization and a non-random distribution among Gypsy subgroups. | Community Genet | 2002 | https://conductscience.org/library/papers/14960875 | PubMed |
| 8 | 14,523,375 | Limb-girdle muscular dystrophy 2I: phenotypic variability within a large consanguineous Bedouin family associated with a novel FKRP mutation. | Eur J Hum Genet | 2004 | https://conductscience.org/library/papers/14523375 | PubMed |
| 9 | 10,766,988 | Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. | Am J Med Genet | 2000 | https://conductscience.org/library/papers/10766988 | PubMed |
| 10 | 11,562,567 | The ABC's of limb-girdle muscular dystrophy: alpha-sarcoglycanopathy, Bethlem myopathy, calpainopathy and more. | Curr Opin Neurol | 2001 | https://conductscience.org/library/papers/11562567 | PubMed |
1 to 10 of 101
See all 101 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
None in this release.
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAPN3 | 825 | PubTator's text mining | https://conductscience.org/library/genes/825 | NCBI Gene |
| CAV3 | 859 | PubTator's text mining | https://conductscience.org/library/genes/859 | NCBI Gene |
| CBLL2 | 158,506 | PubTator's text mining | https://conductscience.org/library/genes/158506 | NCBI Gene |
| DYSF | 8,291 | PubTator's text mining | https://conductscience.org/library/genes/8291 | NCBI Gene |
| FKRP | 79,147 | PubTator's text mining | https://conductscience.org/library/genes/79147 | NCBI Gene |
| LMNA | 4,000 | PubTator's text mining | https://conductscience.org/library/genes/4000 | NCBI Gene |
| MYOT | 9,499 | PubTator's text mining | https://conductscience.org/library/genes/9499 | NCBI Gene |
| SGCA | 6,442 | PubTator's text mining | https://conductscience.org/library/genes/6442 | NCBI Gene |
| SGCB | 6,443 | PubTator's text mining | https://conductscience.org/library/genes/6443 | NCBI Gene |
| SGCD | 6,444 | PubTator's text mining | https://conductscience.org/library/genes/6444 | NCBI Gene |
1 to 10 of 14
See all 14 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15316618
GET https://conductscience.org/api/papers/v1/15316618/references?page=2